{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T08:18:09Z","timestamp":1649146689299},"reference-count":45,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.3892\/etm.2017.4531","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T04:21:23Z","timestamp":1496290883000},"page":"567-574","source":"Crossref","is-referenced-by-count":2,"title":["Clinical analysis of 42 cases of EBV-positive mature T\/NK-cell neoplasms"],"prefix":"10.3892","volume":"14","author":[{"given":"Haiyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"key20180108140319_b1-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"key20180108140319_b2-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project: International peripheral T-cell and natural killer\/T-cell lymphoma study: Pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108140319_b3-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.23205","article-title":"The prognostic significance of lymphopenia in peripheral T-cell and natural killer\/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma Project","volume":"87","author":"Mitrovic","year":"2012","journal-title":"Am J Hematol"},{"key":"key20180108140319_b4-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0609.2012.01796.x","article-title":"Clinical features and prognostic model for extranasal NK\/T-cell lymphoma","volume":"89","author":"Jo","year":"2012","journal-title":"Eur J Haematol"},{"key":"key20180108140319_b5-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"key20180108140319_b6-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11912-012-0245-9","article-title":"NK\/T-cell lymphomas: Pathobiology, prognosis and treatment paradigm","volume":"14","author":"Suzuki","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"key20180108140319_b7-etm-0-0-4531","first-page":"108","article-title":"Epstein-Barr virus-associated diseases in humans","volume":"71","author":"Kawa","year":"2000","journal-title":"Int J Hematol"},{"key":"key20180108140319_b8-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.2007.06835.x","article-title":"Progress in understanding and managing natural killer-cell malignancies","volume":"139","author":"Oshimi","year":"2007","journal-title":"Br J Haematol"},{"key":"key20180108140319_b9-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1346-8138.12322","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders","volume":"41","author":"Park","year":"2014","journal-title":"J Dermatol"},{"key":"key20180108140319_b10-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cyt.12073","article-title":"Epstein-Barr virus encoded RNA detected by in situ hybridization using cytological preparations","volume":"25","author":"Garady","year":"2014","journal-title":"Cytopathology"},{"key":"key20180108140319_b11-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key20180108140319_b12-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"916","DOI":"10.6004\/jnccn.2014.0086","article-title":"Non-Hodgkin's lymphomas, version 2.2014","volume":"12","author":"Zelenetz","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"key20180108140319_b13-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive Non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"key20180108140319_b14-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/leu.2013.212","article-title":"Quantification of circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: Diagnostic and prognostic significance","volume":"28","author":"Kwong","year":"2014","journal-title":"Leukemia"},{"key":"key20180108140319_b15-etm-0-0-4531","first-page":"939","article-title":"Tumor cell nuclear diameter and CD30 expression as potential prognostic parameter in patients with extranodal NK\/T-cell lymphoma, nasal type","volume":"5","author":"Hong","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180108140319_b16-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1182\/blood-2002-09-2908","article-title":"The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: Evidence of origin from lymphocytes involved in innate immunity","volume":"101","author":"Krenacs","year":"2003","journal-title":"Blood"},{"key":"key20180108140319_b17-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"key20180108140319_b18-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.beha.2013.04.007","article-title":"Pathobiology of T-cell and NK-cell lymphomas","volume":"26","author":"Bajor-Dattilo","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20180108140319_b19-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/emm.2014.105","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorders","volume":"47","author":"Cai","year":"2015","journal-title":"Exp Mol Med"},{"key":"key20180108140319_b20-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1158\/0008-5472.CAN-09-0828","article-title":"EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies","volume":"69","author":"Yuling","year":"2009","journal-title":"Cancer Res"},{"key":"key20180108140319_b21-etm-0-0-4531","first-page":"2430","article-title":"Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180108140319_b22-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00000421-199808000-00023","article-title":"Tumor fever in patients with nasopharyngeal carcinoma: Clinical experience of 67 patients","volume":"21","author":"Liaw","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"key20180108140319_b23-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than international prognostic index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"key20180108140319_b24-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"key20180108140319_b25-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"},{"key":"key20180108140319_b26-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2353\/ajpath.2007.061026","article-title":"Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: Implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome","volume":"170","author":"Chuang","year":"2007","journal-title":"Am J Pathol"},{"key":"key20180108140319_b27-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1746-1596-7-133","article-title":"CD20-positive NK\/T-cell lymphoma with indolent clinical course: Report of case and review of literature","volume":"7","author":"Jiang","year":"2012","journal-title":"Diagn Pathol"},{"key":"key20180108140319_b28-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2559.2010.03584.x","article-title":"CD20 expression in natural killer T cell lymphoma","volume":"57","author":"Gill","year":"2010","journal-title":"Histopathology"},{"key":"key20180108140319_b29-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jclinpath-2015-203188","article-title":"Primary gastric extranodal natural killer\/T-cell lymphoma, nasal type, with acquisition of CD20 expression in the subcutaneous relapse: Report of a case with literature review","volume":"68","author":"Huang","year":"2015","journal-title":"J Clin Pathol"},{"key":"key20180108140319_b30-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00428-015-1845-1","article-title":"CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma","volume":"467","author":"Chuang","year":"2015","journal-title":"Virchows Arch"},{"key":"key20180108140319_b31-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.humimm.2013.09.001","article-title":"Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations","volume":"74","author":"Wada","year":"2013","journal-title":"Hum Immunol"},{"key":"key20180108140319_b32-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/10428199309148200","article-title":"Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies","volume":"10","author":"Karsan","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"key20180108140319_b33-etm-0-0-4531","first-page":"1921","article-title":"Prognostic significance of survivin expression in diffuse large B-cell lymphomas","volume":"96","author":"Adida","year":"2000","journal-title":"Blood"},{"key":"key20180108140319_b34-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"e74853","DOI":"10.1371\/journal.pone.0074853","article-title":"Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"key":"key20180108140319_b35-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-11-0397","article-title":"Metabolic imaging: A link between lactate dehydrogenase A, lactate, and tumor phenotype","volume":"17","author":"Serganova","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180108140319_b36-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"key20180108140319_b37-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","article-title":"The follicular lymphoma international prognostic index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome","volume":"108","author":"Buske","year":"2006","journal-title":"Blood"},{"key":"key20180108140319_b38-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00277-015-2448-2","article-title":"Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma","volume":"94","author":"Tomita","year":"2015","journal-title":"Ann Hematol"},{"key":"key20180108140319_b39-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8722-5-27","article-title":"Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK\/T cell lymphoma","volume":"5","author":"Chauchet","year":"2012","journal-title":"J Hematol Oncol"},{"key":"key20180108140319_b40-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2011.08651.x","article-title":"British and Committee for Standards in Haematology: Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)","volume":"153","author":"Dearden","year":"2011","journal-title":"Br J Haematol"},{"key":"key20180108140319_b41-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"288","DOI":"10.6004\/jnccn.2010.0021","article-title":"NCCN clinical practice guidelines in oncology: Non-Hodgkin's lymphomas","volume":"8","author":"Zelenetz","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"key20180108140319_b42-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/sj.leu.2403955","article-title":"Natural killer-cell malignancies: Diagnosis and treatment","volume":"19","author":"Kwong","year":"2005","journal-title":"Leukemia"},{"key":"key20180108140319_b43-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0037-1963(03)00136-7","article-title":"Natural killer cell neoplasms: A distinctive group of highly aggressive lymphomas\/leukemias","volume":"40","author":"Cheung","year":"2003","journal-title":"Semin Hematol"},{"key":"key20180108140319_b44-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-Cell lymphoma: Analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180108140319_b45-etm-0-0-4531","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","article-title":"Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy","volume":"120","author":"Wang","year":"2012","journal-title":"Blood"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T19:36:47Z","timestamp":1515440207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.3892\/etm.2017.4531"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4531","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}